Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Genitourinary 2Myeloid 1Classical hematology 1

Conditions

Metabolism, Inborn Errors 1Lymphoma, Non-Hodgkin 1Leukemia 1Immunologic Deficiency Syndromes 1Hemoglobinopathies 1Congenital Bone Marrow Failure Syndromes 1Bone Marrow Failure Disorders 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 11Cyclophosphamide 11Whole-Body Irradiation 8Mycophenolic Acid 8Busulfan 7fludarabine 6Tacrolimus 6Peripheral Blood Stem Cell Transplantation 6Melphalan 5Rituximab 4Biopsy 4Azacitidine 4venetoclax 3thymoglobulin 3apixaban 3Methotrexate 3Cyclosporine 3Antilymphocyte Serum 3decitabine and cedazuridine drug combination 2Vorinostat 2Vancomycin 2Tretinoin 2Specimen Handling 2Sirolimus 2Lenalidomide 2Injections 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Decitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clinical Trials, Phase I as Topic × Classical hematology × 90 days × Clear all
NCT06839456 2026-04-15

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Children's Hospital of Philadelphia

Phase 1/2 Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Non-Hodgkin, Metabolism, Inborn Errors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡